Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

tags : Test    crawled time : 12:20    save search

The Rockefeller Foundation Commits USD 100 Million to Test and Scale Climate and Health Solutions Globally
Published: 2023-12-02 (Crawled : 12:20) - prnewswire.com
SNY | News | $46.66 -2.16% -2.21% 1.7M twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
SNYNF | News | $94.25 -2.18% 480 twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

test health solutions 100
Yield10 Bioscience Announces Positive Results in the First Field Test of Stacked Herbicide Tolerance Traits in Camelina, Supporting Large Acreage Production of Low-carbon Intensity Feedstock Oil for the Biofuel Market
Published: 2023-08-02 (Crawled : 12:20) - globenewswire.com
YTEN | $0.2345 -8.76% -9.59% 1.1M twitter stocktwits trandingview |
Health Technology
| | O: -3.08% H: 0.0% C: -7.73%

test positive bioscience results market
Thermo Fisher Scientific Launches Scalable Diomni Enterprise Software for Molecular Diagnostics Labs and Test Developers
Published: 2023-07-13 (Crawled : 12:20) - biospace.com/
TMO | News | $577.39 0.49% 0.0% 2M twitter stocktwits trandingview |
Health Technology
| | O: 1.73% H: 0.27% C: -1.56%

test software diagnostics molecular
Versus Systems Launches Sign Up for Real-Money Skill-Based Gaming Beta Test
Published: 2023-07-12 (Crawled : 12:20) - globenewswire.com
VRSSF | $0.7272 -0.66% 120K twitter stocktwits trandingview |
n/a
| | O: 0.37% H: 2.14% C: 2.14%
VS | $1.39 2.21% 2.16% 14K twitter stocktwits trandingview |
Information
| | O: 0.44% H: 2.88% C: -0.02%

test gaming
EXOSOME DIAGNOSTICS RELEASES INTERIM RESULTS FROM CLINICAL STUDY OF PROSTATE CANCER RISK TEST
Published: 2023-05-18 (Crawled : 12:20) - biospace.com/
TECH | $63.48 -0.33% -0.33% 980K twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 1.68% C: 1.5%

test cancer risk diagnostics results study
Biodesix Announces New Clinical Utility Evidence for the Nodify XL2® Nodule Risk Assessment Test to Be Presented at ATS 2023 International Conference
Published: 2023-05-18 (Crawled : 12:20) - biospace.com/
BDSX | $1.26 -1.56% -1.59% 7.1K twitter stocktwits trandingview |
Health Services
| | O: -1.65% H: 4.2% C: -4.2%

xl2 conference test international risk
NeoGenomics Announces Commercial Availability of the RaDaR(R) Molecular Residual Disease Test
Published: 2023-03-16 (Crawled : 12:20) - biospace.com/
NEO | $14.03 -0.92% -0.93% 540K twitter stocktwits trandingview |
Health Services
| | O: -0.64% H: 5.52% C: 5.19%

disease test commercial molecular
BD Receives FDA 510(k) Clearance for First-of-Its-Kind High-Throughput Diagnostic Test for Infectious Vaginitis
Published: 2023-03-16 (Crawled : 12:20) - biospace.com/
BDX | $233.83 -0.23% 3.49% 780K twitter stocktwits trandingview |
Health Technology
| | O: -0.52% H: 2.22% C: 2.04%

fda test diagnostic clearance infectious vaginitis
Pharmanovia to Market GHRYVELIN™ (Macimorelin) in the European Economic Area (EEA) and UK as Diagnostic Test for Growth Hormone Deficiency (GHD)
Published: 2023-03-16 (Crawled : 12:20) - globenewswire.com
AEZS | $1.97 0.73% 6K twitter stocktwits trandingview |
Health Technology
| | O: 0.75% H: 4.09% C: 2.23%

test diagnostic growth market hormone
BioReference Now Offers the Only FDA-Approved Dual-Stain Triage Test to Enhance Cervical Cancer Screenings
Published: 2023-02-09 (Crawled : 12:20) - prnewswire.com
OPK | $1.225 -2.0% -2.04% 6.1M twitter stocktwits trandingview |
Health Technology
| | O: 1.56% H: 1.54% C: -3.85%

test cancer
Journal of Precision Medicine publication confirms GeneType Risk Test outperforms traditional risk assessments for breast cancer
Published: 2022-09-29 (Crawled : 12:20) - globenewswire.com
GENE | News 0 d | $2.16 -9.62% -10.65% 28K twitter stocktwits trandingview |
Health Technology
| | O: 0.81% H: 0.44% C: -2.41%

risk test cancer publication
Biomerica’s Aware® Breast Self Exam and EZ Detect™ Colon Disease Test Now Available on Amazon and Fulfilled by Amazon
Published: 2022-09-29 (Crawled : 12:20) - globenewswire.com
BMRA | $0.691 -4.29% -4.49% 660K twitter stocktwits trandingview |
Health Technology
| | O: -1.28% H: 5.94% C: 2.84%

aware amazon disease test
Say Goodbye to the Crash Test Dummy? Altair Survey Reveals Digital Twin Technology May Make Physical Prototyping Obsolete in the Next 4-6 Years
Published: 2022-09-13 (Crawled : 12:20) - prnewswire.com
ALTR | $83.49 -0.35% -0.35% 260K twitter stocktwits trandingview |
Technology Services
| | O: -3.05% H: 0.81% C: -1.68%

test technology
Evaporation Test Work Underway at HMN Li Project
Published: 2022-08-19 (Crawled : 12:20) - prnewswire.com
PKX | News | $71.38 -0.14% 0.0% 150K twitter stocktwits trandingview |
Non-Energy Minerals
| | O: -1.2% H: 0.0% C: -1.03%
LTHM | $16.51 -1.58% 53M twitter stocktwits trandingview |
Process Industries
| | O: -2.29% H: 0.23% C: -4.51%

work test
Chembio Diagnostics Evaluates Monkeypox Rapid Point-of-Care Test Development
Published: 2022-08-16 (Crawled : 12:20) - globenewswire.com
CEMI | $0.455 -5.25% 350K twitter stocktwits trandingview |
Health Technology
| | O: 8.71% H: 0.0% C: 0.0%

monkeypox test diagnostics
Bluejay Completes Planned Clinical Studies for Symphony IL-6 Test
Published: 2022-07-06 (Crawled : 12:20) - biospace.com/
BJDX | $0.625 0.8% 12K twitter stocktwits trandingview |
| | O: 1.87% H: 10.09% C: 5.5%

test il-6
GeneType Risk Assessment Test onboarding in 16 clinics
Published: 2022-07-01 (Crawled : 12:20) - globenewswire.com
GENE | News 0 d | $2.16 -9.62% -10.65% 28K twitter stocktwits trandingview |
Health Technology
| | O: -0.86% H: 5.3% C: 5.22%

risk test
Akoya Biosciences to Partner with Acrivon Therapeutics for the Clinical Development of Acrivon’s Proprietary OncoSignature® Test into a Companion Diagnostic
Published: 2022-06-28 (Crawled : 12:20) - globenewswire.com
AKYA | News | $3.815 0.13% 0.13% 100K twitter stocktwits trandingview |
Professional, Scientific, and T...
| | O: 1.0% H: 4.77% C: 3.37%
LLY | News | $732.2 -1.81% 0.18% 2.1M twitter stocktwits trandingview |
Health Technology
| | O: 0.99% H: 0.0% C: 0.0%

oncosignature test diagnostic therapeutics
CHIPOTLE TESTS MEXICAN CAULIFLOWER RICE
Published: 2022-06-16 (Crawled : 12:20) - prnewswire.com
CMG | News | $2926.76 0.4% 2.84% 360K twitter stocktwits trandingview |
Consumer Services
| | O: 0.15% H: 0.0% C: -2.64%

rice test
Adaptive Biotechnologies Launches T-Detect™ Lyme, A New T-Cell Clinical Test for the Detection of Early Lyme DiseaseT-Detect Lyme
Published: 2022-06-15 (Crawled : 12:20) - biospace.com/
ADPT | $2.595 0.58% 0.39% 2M twitter stocktwits trandingview |
Commercial Services
| | O: 4.11% H: 11.78% C: 8.66%

test t-cell
Gainers vs Losers
62% 38%

Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M twitter stocktwits trandingview |
Consumer Services

BOF | $1.99 70.09% 41.21% 110M twitter stocktwits trandingview |

ILAG | $0.51 6.03% 40.62% 1.7M twitter stocktwits trandingview |

LICN | $0.941 68.04% 40.49% 15M twitter stocktwits trandingview |

AMST | $3.31 65.5% 39.58% 70M twitter stocktwits trandingview |
Technology Services

MTC | $3.615 61.38% 38.04% 9.3M twitter stocktwits trandingview |
Technology Services

WIMI | $1.15 58.53% 36.92% 19M twitter stocktwits trandingview |
Technology Services

AIH | $0.45 12.5% 30.92% 320K twitter stocktwits trandingview |
Health Services

MULN | News | $3.78 38.46% 27.78% 13M twitter stocktwits trandingview |
Information

RILY | $29.86 37.48% 27.26% 12M twitter stocktwits trandingview |
Finance


Your saved searches
Save your searches and get alerts when important news are released.